Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Diagnostics and laboratory products / Clinical consumables and general diagnostics / Hospital core-lab specimen collection and handling consumables

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Hospital core-lab specimen collection and handling consumables

Single-use blood-collection tubes (vacutainers), needles, holders, transfer devices, slides and smears, and specimen-handling plastics purchased by hospital laboratories and phlebotomy units to collect, transport and prepare patient samples for the assays run on the hospital's own analysers. Excludes rapid/point-of-care test kits and the assay reagents themselves.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
75 /100
for B2B sellers
Evidence
not sized
1 source · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Hospitals (hospital laboratories, phlebotomy and specimen receiving departments)
Buying centre
Lab director / head of core lab, with procurement and infection-control and nursing-education sign-off; centralised IDN or GPO contracting for larger systems
Buying triggers
  • Test volume growth from ageing and chronic disease
  • Hospital consolidation and centralisation of lab operations
  • Reagent-rental instrument placements that lock in proprietary tube and needle formats
  • Single-use and infection-prevention mandates
Pains
  • Fragmented multi-brand consumable portfolios causing workflow inconsistency and retesting
  • Needlestick and exposure injury risk in high-volume phlebotomy
  • Specimen rejection and haemolysis rates that delay results and waste analyser capacity
  • Price pressure from GPO contracts and tenders
Scores (1–5)
Pain intensity4
Purchasing power4
Reachability4
Growth3

How this was sized

Not sized yet

No source sizes this consumables-only pool. Bottom-up framing only: hospital laboratories were 49.3% of the worldwide laboratory diagnostics market in 2025, which was USD 110.85bn [8], i.e. roughly USD 54.6bn of hospital-lab diagnostics spend. Applying a stated consumables share of 10-15% of hospital-lab diagnostics spend (blood tubes, needles, slides, plastics are a minority of the reagent/instrument mix) gives a hospital-lab consumables pool of roughly USD 5.5-8.2bn, i.e. USD 5,500-8,200m. Arithmetic: 110.85bn x 49.3% = 54.65bn; x 10-15% = 5.5-8.2bn. Confidence Low: the 10-15% consumables share is an assumption, not a sourced figure, and the source market definitions differ (reagents+consumables+instruments vs. tests).

Sources

Alongside it in Clinical consumables and general diagnostics

// Sell into Hospital core-lab specimen collection and handling consumables

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.